# BREAST ADM Trial for Alloplastic Breast Reconstruction

> **NCT04661501** · NA · RECRUITING · sponsor: **University of British Columbia** · enrollment: 328 (estimated)

## Conditions studied

- Breast Reconstruction

## Interventions

- **DEVICE:** AlloDerm
- **DEVICE:** AlloMax
- **DEVICE:** DermACELL
- **DEVICE:** Flex HD

## Key facts

- **NCT ID:** NCT04661501
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-11-25
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 328 (ESTIMATED)
- **Last updated:** 2024-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04661501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04661501, "BREAST ADM Trial for Alloplastic Breast Reconstruction". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04661501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
